Redemptions from low-yielding fixed-income classes cut into positive flows on the equity side in August. Inflows for the month barely topped USD 1 billion.
Brazilian mutual funds suffered BRL 20 billion in outflows in April
As investors fretted with the weak economic recovery, the main redemptions were driven by the Fixed Income class, with net outflows of BRL 8.9 billion.
Vanguard launches first local product in Mexico
The Vanguard FTSE BIVA Mexico Equity ETF (VMEX) tracks the country’s BIVA index, which accounts for 97% of the Mexican equity market.
Vontobel Wealth Management adds staff to target wealthy clients in Mexico and Brazil
Vontobel is seeking to hire bankers with Mexican client books for its Zurich office by year-end, according to published reports. But it has not ruled out opening a rep office in Mexico.
CCR Monthly Approval Report – April 2019
iShares led with 11 ETFs registered in the month, while M&G followed with five mutual funds. Invesco, Nordea,Baillie Gifford, and Vontobel, joined the list along with four alternatives products.
Sura retail offering to include locally listed JPM UCITS
The deal was made possible by JPM's listing of 29 Lux-domiciled funds on the Chilean Stock Exchange, which grants the products public-offering status
Natixis fills recently vacated sales post for Colombia, Peru and Panama
Natixis hired Bogotá-based BNP veteran Lucas Pérez, replacing sales manager Daniel Arias Kluge, who moved to Miami to join Pimco. Pérez reports to Jose Luis León.
Uruguay’s Criteria to distribute Prestige Funds in Southern Cone
The agreement with the UK alts firm responds to what Criteria's William Reekstin views as strong appetite for "investment opportunities in the real economy with low correlation to the public financial markets."
BlackRock: Global institutions shifting from public to private risk
“As the economic cycle turns, we believe that private markets can help clients navigate this more challenging environment,” said BlackRock's Edwin Conway.
CCR Monthly Approval Report – December 2018
Products from BNP Paribas, Lyxor, Fidelity, Amundi and Man won approval, as did Avenue Capital Group to offer its alternative products.











